Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 5701 to 5708 of 5708 entries
Sorted by: Best Match Show Resources per page
Rational design of mixed nanomicelle eye drops with structural integrity investigation.

Acta biomaterialia

Sun L, Zhang M, Shi Y, Fang L, Cao F.
PMID: 35032720
Acta Biomater. 2022 Jan 12; doi: 10.1016/j.actbio.2022.01.014. Epub 2022 Jan 12.

Chitosan oligosaccharide-stearic acid-Valyl-Valyl-Valine/1-2-Dioleoyl-sn-glycero-3-phosphoethanolamine (CSO-SA-VVV

Cite
Sun L, Zhang M, Shi Y, et al. Rational design of mixed nanomicelle eye drops with structural integrity investigation. Acta Biomater. 2022;doi: 10.1016/j.actbio.2022.01.014.
Sun, L., Zhang, M., Shi, Y., Fang, L., & Cao, F. (2022). Rational design of mixed nanomicelle eye drops with structural integrity investigation. Acta biomaterialia, . https://doi.org/10.1016/j.actbio.2022.01.014
Sun, Liping, et al. "Rational design of mixed nanomicelle eye drops with structural integrity investigation." Acta biomaterialia vol. (2022). doi: https://doi.org/10.1016/j.actbio.2022.01.014
Sun L, Zhang M, Shi Y, Fang L, Cao F. Rational design of mixed nanomicelle eye drops with structural integrity investigation. Acta Biomater. 2022 Jan 12; doi: 10.1016/j.actbio.2022.01.014. Epub 2022 Jan 12. PMID: 35032720.
Copy Download .nbib Format: NLM
Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma.

Leukemia

Usmani SZ, Karanes C, Bensinger WI, D'Souza A, Raje N, Tuchman SA, Sborov D, Laubach JP, Bianchi G, Kanagavel D, Saleem R, Dubin F, Campana F, Richardson PG.
PMID: 34050260
Leukemia. 2021 Dec;35(12):3526-3533. doi: 10.1038/s41375-021-01262-w. Epub 2021 May 28.

Part B of this phase 1b study (ClinicalTrials.gov number, NCT02283775) evaluated safety and efficacy of a fixed-volume infusion of isatuximab, an anti-CD38 monoclonal antibody, in combination with pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma patients. Isatuximab (10 mg/kg...

Cite
Usmani SZ, Karanes C, Bensinger WI, et al. Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma. Leukemia. 2021;35(12):3526-3533doi: 10.1038/s41375-021-01262-w.
Usmani, S. Z., Karanes, C., Bensinger, W. I., D'Souza, A., Raje, N., Tuchman, S. A., Sborov, D., Laubach, J. P., Bianchi, G., Kanagavel, D., Saleem, R., Dubin, F., Campana, F., & Richardson, P. G. (2021). Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma. Leukemia, 35(12), 3526-3533. https://doi.org/10.1038/s41375-021-01262-w
Usmani, Saad Z, et al. "Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma." Leukemia vol. 35,12 (2021): 3526-3533. doi: https://doi.org/10.1038/s41375-021-01262-w
Usmani SZ, Karanes C, Bensinger WI, D'Souza A, Raje N, Tuchman SA, Sborov D, Laubach JP, Bianchi G, Kanagavel D, Saleem R, Dubin F, Campana F, Richardson PG. Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma. Leukemia. 2021 Dec;35(12):3526-3533. doi: 10.1038/s41375-021-01262-w. Epub 2021 May 28. PMID: 34050260; PMCID: PMC8632673.
Copy Download .nbib Format: NLM
A Case of Severe COVID-19 Pneumonia Diagnosed in Bronchoscopy With Negative Repeated Nasopharyngeal Swabs.

Journal of medical cases

Shukha Y, Makhoul K, Abu-Elhija J, Hayek T, Hamoud S.
PMID: 34429794
J Med Cases. 2021 Jun;12(6):217-219. doi: 10.14740/jmc3679. Epub 2021 Mar 24.

Coronavirus disease 2019 (COVID-19) is a worldwide pandemic that had emerged in China since December 2019. The disease affects all age groups, with clinical manifestations in the spectrum from asymptomatic to rapidly lethal multi-organ failure, mainly involving the respiratory...

Cite
Shukha Y, Makhoul K, Abu-Elhija J, et al. A Case of Severe COVID-19 Pneumonia Diagnosed in Bronchoscopy With Negative Repeated Nasopharyngeal Swabs. J Med Cases. 2021;12(6):217-219doi: 10.14740/jmc3679.
Shukha, Y., Makhoul, K., Abu-Elhija, J., Hayek, T., & Hamoud, S. (2021). A Case of Severe COVID-19 Pneumonia Diagnosed in Bronchoscopy With Negative Repeated Nasopharyngeal Swabs. Journal of medical cases, 12(6), 217-219. https://doi.org/10.14740/jmc3679
Shukha, Yousef, et al. "A Case of Severe COVID-19 Pneumonia Diagnosed in Bronchoscopy With Negative Repeated Nasopharyngeal Swabs." Journal of medical cases vol. 12,6 (2021): 217-219. doi: https://doi.org/10.14740/jmc3679
Shukha Y, Makhoul K, Abu-Elhija J, Hayek T, Hamoud S. A Case of Severe COVID-19 Pneumonia Diagnosed in Bronchoscopy With Negative Repeated Nasopharyngeal Swabs. J Med Cases. 2021 Jun;12(6):217-219. doi: 10.14740/jmc3679. Epub 2021 Mar 24. PMID: 34429794; PMCID: PMC8279280.
Copy Download .nbib Format: NLM
Diagnosing Disseminated Nocardiosis in a Patient With COVID-19 Pneumonia.

Journal of medical cases

Atemnkeng F, Ducey J, Khalil A, Elemam A, Diaz K.
PMID: 34429798
J Med Cases. 2021 Aug;12(8):319-324. doi: 10.14740/jmc3716. Epub 2021 Jul 03.

Signs and symptoms of atypical pneumonia include fever, shortness of breath, cough, and chest pain. During the coronavirus disease 2019 (COVID-19) pandemic, identifying other causes of febrile respiratory illness in patients who tested positive for COVID-19 has been very...

Cite
Atemnkeng F, Ducey J, Khalil A, et al. Diagnosing Disseminated Nocardiosis in a Patient With COVID-19 Pneumonia. J Med Cases. 2021;12(8):319-324doi: 10.14740/jmc3716.
Atemnkeng, F., Ducey, J., Khalil, A., Elemam, A., & Diaz, K. (2021). Diagnosing Disseminated Nocardiosis in a Patient With COVID-19 Pneumonia. Journal of medical cases, 12(8), 319-324. https://doi.org/10.14740/jmc3716
Atemnkeng, Francis, et al. "Diagnosing Disseminated Nocardiosis in a Patient With COVID-19 Pneumonia." Journal of medical cases vol. 12,8 (2021): 319-324. doi: https://doi.org/10.14740/jmc3716
Atemnkeng F, Ducey J, Khalil A, Elemam A, Diaz K. Diagnosing Disseminated Nocardiosis in a Patient With COVID-19 Pneumonia. J Med Cases. 2021 Aug;12(8):319-324. doi: 10.14740/jmc3716. Epub 2021 Jul 03. PMID: 34429798; PMCID: PMC8279285.
Copy Download .nbib Format: NLM
Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia.

Journal of infection and public health

AlQahtani H, AlBilal S, Mahmoud E, Aldibasi O, Alharbi A, Shamas N, Alsaedy A, Owaidah K, Alqahtani FY, Aleanizy FS, Arishi H, Baharoon S, Bosaeed M.
PMID: 34883296
J Infect Public Health. 2021 Nov 24;15(1):36-41. doi: 10.1016/j.jiph.2021.11.017. Epub 2021 Nov 24.

INTRODUCTION: Immunomodulators, including dexamethasone (DEX), have been recommended by the Infectious Disease Society of America (IDSA) to treat moderate, severe, and critical COVID-19. Tocilizumab (TCZ) was added to the treatment recommendations based on recent data from two large randomized...

Cite
AlQahtani H, AlBilal S, Mahmoud E, et al. Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia. J Infect Public Health. 2021;15(1):36-41doi: 10.1016/j.jiph.2021.11.017.
AlQahtani, H., AlBilal, S., Mahmoud, E., Aldibasi, O., Alharbi, A., Shamas, N., Alsaedy, A., Owaidah, K., Alqahtani, F. Y., Aleanizy, F. S., Arishi, H., Baharoon, S., & Bosaeed, M. (2021). Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia. Journal of infection and public health, 15(1), 36-41. https://doi.org/10.1016/j.jiph.2021.11.017
AlQahtani, Hajar, et al. "Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia." Journal of infection and public health vol. 15,1 (2021): 36-41. doi: https://doi.org/10.1016/j.jiph.2021.11.017
AlQahtani H, AlBilal S, Mahmoud E, Aldibasi O, Alharbi A, Shamas N, Alsaedy A, Owaidah K, Alqahtani FY, Aleanizy FS, Arishi H, Baharoon S, Bosaeed M. Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia. J Infect Public Health. 2021 Nov 24;15(1):36-41. doi: 10.1016/j.jiph.2021.11.017. Epub 2021 Nov 24. PMID: 34883296; PMCID: PMC8611824.
Copy Download .nbib Format: NLM
Ascaridia galli challenge model for worm propagation in young chickens with or without immunosuppression.

Veterinary parasitology

Feyera T, Shifaw AY, Ruhnke I, Sharpe B, Elliott T, Walkden-Brown SW.
PMID: 34883322
Vet Parasitol. 2021 Nov 26;301:109624. doi: 10.1016/j.vetpar.2021.109624. Epub 2021 Nov 26.

With the continued growth of free-range egg production, the importance of the chicken roundworm Ascaridia galli is increasing. Investigations into this parasite would be facilitated by the availability of characterised strains and clear guidelines on optimal methods of multiplication...

Cite
Feyera T, Shifaw AY, Ruhnke I, et al. Ascaridia galli challenge model for worm propagation in young chickens with or without immunosuppression. Vet Parasitol. 2021;301:109624doi: 10.1016/j.vetpar.2021.109624.
Feyera, T., Shifaw, A. Y., Ruhnke, I., Sharpe, B., Elliott, T., & Walkden-Brown, S. W. (2021). Ascaridia galli challenge model for worm propagation in young chickens with or without immunosuppression. Veterinary parasitology, 301109624. https://doi.org/10.1016/j.vetpar.2021.109624
Feyera, Teka, et al. "Ascaridia galli challenge model for worm propagation in young chickens with or without immunosuppression." Veterinary parasitology vol. 301 (2021): 109624. doi: https://doi.org/10.1016/j.vetpar.2021.109624
Feyera T, Shifaw AY, Ruhnke I, Sharpe B, Elliott T, Walkden-Brown SW. Ascaridia galli challenge model for worm propagation in young chickens with or without immunosuppression. Vet Parasitol. 2021 Nov 26;301:109624. doi: 10.1016/j.vetpar.2021.109624. Epub 2021 Nov 26. PMID: 34883322.
Copy Download .nbib Format: NLM
Critical respiratory failure in pregnancy complicated with COVID-19: A case report.

Case reports in women's health

Chinen Y, Kinjyo Y, Mekaru K, Kinjo T, Higure Y, Kinjo T, Miyagi K, Yamada H, Masamoto H, Goya H, Yoshida T, Maeshiro S, Nakamatsu M, Fujita J, Aoki Y.
PMID: 33777708
Case Rep Womens Health. 2021 Apr;30:e00309. doi: 10.1016/j.crwh.2021.e00309. Epub 2021 Mar 23.

The case is presented of a 29-year-old primiparous woman who was COVID-19-positive at 34 weeks of gestation and who developed severe acute respiratory distress syndrome. After a four-day history of fever and mild dyspnea, she was referred to hospital....

Cite
Chinen Y, Kinjyo Y, Mekaru K, et al. Critical respiratory failure in pregnancy complicated with COVID-19: A case report. Case Rep Womens Health. 2021;30:e00309doi: 10.1016/j.crwh.2021.e00309.
Chinen, Y., Kinjyo, Y., Mekaru, K., Kinjo, T., Higure, Y., Kinjo, T., Miyagi, K., Yamada, H., Masamoto, H., Goya, H., Yoshida, T., Maeshiro, S., Nakamatsu, M., Fujita, J., & Aoki, Y. (2021). Critical respiratory failure in pregnancy complicated with COVID-19: A case report. Case reports in women's health, 30e00309. https://doi.org/10.1016/j.crwh.2021.e00309
Chinen, Yukiko, et al. "Critical respiratory failure in pregnancy complicated with COVID-19: A case report." Case reports in women's health vol. 30 (2021): e00309. doi: https://doi.org/10.1016/j.crwh.2021.e00309
Chinen Y, Kinjyo Y, Mekaru K, Kinjo T, Higure Y, Kinjo T, Miyagi K, Yamada H, Masamoto H, Goya H, Yoshida T, Maeshiro S, Nakamatsu M, Fujita J, Aoki Y. Critical respiratory failure in pregnancy complicated with COVID-19: A case report. Case Rep Womens Health. 2021 Apr;30:e00309. doi: 10.1016/j.crwh.2021.e00309. Epub 2021 Mar 23. PMID: 33777708; PMCID: PMC7986466.
Copy Download .nbib Format: NLM
High Sensitivity of the Circadian Clock in the Hippocampal Dentate Gyrus to Glucocorticoid- and GSK3-Beta-Dependent Signals.

Neuroendocrinology

Liška K, Sládek M, Houdek P, Shrestha N, Lužná V, Ralph MR, Sumová A.
PMID: 34111876
Neuroendocrinology. 2021 Jun 10; doi: 10.1159/000517689. Epub 2021 Jun 10.

AIMS: Circadian clocks in the hippocampus (HPC) align memory processing with appropriate time of day. Our study was aimed at ascertaining the specificity of glycogen synthase kinase 3-beta (GSK3β)- and glucocorticoid (GC)-dependent pathways in the entrainment of clocks in...

Cite
Liška K, Sládek M, Houdek P, et al. High Sensitivity of the Circadian Clock in the Hippocampal Dentate Gyrus to Glucocorticoid- and GSK3-Beta-Dependent Signals. Neuroendocrinology. 2021;doi: 10.1159/000517689.
Liška, K., Sládek, M., Houdek, P., Shrestha, N., Lužná, V., Ralph, M. R., & Sumová, A. (2021). High Sensitivity of the Circadian Clock in the Hippocampal Dentate Gyrus to Glucocorticoid- and GSK3-Beta-Dependent Signals. Neuroendocrinology, . https://doi.org/10.1159/000517689
Liška, Karolína, et al. "High Sensitivity of the Circadian Clock in the Hippocampal Dentate Gyrus to Glucocorticoid- and GSK3-Beta-Dependent Signals." Neuroendocrinology vol. (2021). doi: https://doi.org/10.1159/000517689
Liška K, Sládek M, Houdek P, Shrestha N, Lužná V, Ralph MR, Sumová A. High Sensitivity of the Circadian Clock in the Hippocampal Dentate Gyrus to Glucocorticoid- and GSK3-Beta-Dependent Signals. Neuroendocrinology. 2021 Jun 10; doi: 10.1159/000517689. Epub 2021 Jun 10. PMID: 34111876.
Copy Download .nbib Format: NLM
Showing 5701 to 5708 of 5708 entries